VT
TMO icon

Vise Technologies’s Thermo Fisher Scientific TMO Stock Holding History

Vise Technologies’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57M Buy
9,112
+1,405
+18% +$674K 0.05% 298
2026
Q1 		$4.47M Hold
7,707
– – 0.09% 190
2025
Q4 		$4.47M Buy
7,707
+2,354
+44% +$1.33M 0.09% 191
2025
Q3 		$2.6M Buy
5,353
+168
+3% +$78.2K 0.1% 201
2025
Q2 		$2.1M Buy
+5,185
New +$2.17M 0.09% 244
2024
Q4 		$2.17M Buy
4,170
+2,439
+141% +$1.34M 0.18% 125
2024
Q3 		$1.07M Buy
1,731
+879
+103% +$520K 0.14% 152
2024
Q2 		$471K Buy
852
+63
+8% +$36.1K 0.08% 234
2024
Q1 		$459K Buy
789
+71
+10% +$39.8K 0.09% 217
2023
Q4 		$381K Buy
718
+90
+14% +$43.6K 0.08% 229
2023
Q3 		$318K Sell
628
-191
-23% -$102K 0.08% 230
2023
Q2 		$427K Sell
819
-87
-10% -$46.9K 0.1% 193
2023
Q1 		$522K Buy
906
+346
+62% +$195K 0.14% 159
2022
Q4 		$308K Sell
560
-161
-22% -$85.3K 0.1% 229
2022
Q3 		$366K Buy
721
+70
+11% +$39.2K 0.14% 179
2022
Q2 		$354K Buy
+651
New +$358K 0.14% 174

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vise Technologies's TMO Position: Q2 2026 in Review

Vise Technologies increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, buying an estimated $674K and bringing the position to 9,112 shares worth $4.57M. The position accounts for 0.05% of the portfolio, ranked #298.

Vise Technologies first reported a position in TMO in Q2 2022 and has held it in 16 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Vise Technologies held 9,112 shares of Thermo Fisher Scientific worth $4.57M as of Q2 2026.
  • Vise Technologies bought 1,405 Thermo Fisher Scientific shares in Q2 2026, an estimated $674K.
  • Thermo Fisher Scientific made up 0.05% of Vise Technologies's portfolio in Q2 2026, its #298 holding.
  • Vise Technologies first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 16 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.